EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Integrating SERPINE1 Genotype With Clinical Indicators Improves Venous Thromboembolism Risk Prediction in Cancer Patients: A Retrospective Cohort Study From Xinjiang

Fan Guo iD, Yiliminuer Keremu, Gang Zhao, Huiting Hu, Yufei Wu, Xiaolu Yu, Chongxiao Hao, Weina Kong, Xiumin Ma

Clinical and Applied Thrombosis/Hemostasis · 2026-01 · 32

DOI: 10.1177/10760296261503703 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 02.11.2026. Verfasst von Fan Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Center, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Plasminogen Activator Inhibitor 1, Venous Thromboembolism, Neoplasms. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Natural Science Foundation of Xinjiang Uygur Autonomous region, the Open Research Project of the Institute of Basic Medical Sciences in Xinjiang Medical University, the Open Project of Xinjiang Medical Engineering Innovation Research and Biomedical Transformation Key Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop and validate a venous thromboembolism (VTE) risk prediction model integrating genetic polymorphisms and routine clinical indicators in a cohort of cancer patients from Xinjiang, China.

Methods

A retrospective study was conducted on 1135 cancer patients (179 with VTE, 956 without) at Affiliated Cancer Hospital of Xinjiang Medical University between March 2024 and May 2025. Six gene polymorphisms ( SERPINE1 , SERPINC1 , PROC , MTHFR , F5 , F2 ) and clinical predictors were assessed. Chi-square tests and logistic regression identified independent predictors for model construction. Model performance was evaluated using ROC analysis, and three clinically optimized cut-off values were defined.

Results

The SERPINE1 4G allele was identified as a strong genetic risk factor for VTE (4G/4G genotype: OR=2.330, 95%CI: 1.378-3.942; 4G/5G genotype: OR=2.399, 95%CI: 1.411-4.078). No significant associations were found for the other five genes. Age (OR=1.022, 95%CI: 1.008-1.037), D-dimer level (OR=1.288, 95%CI: 1.186-1.399), and hemoglobin level (OR=0.987, 95%CI: 0.979-0.995) were independent clinical predictors ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasminogen Activator Inhibitor 1Venous ThromboembolismNeoplasmsHumansRetrospective StudiesFemaleMaleChinaMiddle AgedGenotypeRisk FactorsAgedAdult

Stichwörter der Autor:innen

Cancer-Associated ThrombosisClinical PredictorsPrediction ModelRisk StratificationSERPINE1

Substanzen

Plasminogen Activator Inhibitor 1SERPINE1 protein, human

Autor:innen und Institutionen

  • Department of Medical Laboratory Center, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
  • Department of Blood Transfusion, Affiliated Traditional Chinese Medicine Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
  • Institute of Basic Medical Sciences, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.

ORCID-Profile: Fan Guo

Förderung

  • the Natural Science Foundation of Xinjiang Uygur Autonomous region
  • the Open Research Project of the Institute of Basic Medical Sciences in Xinjiang Medical University
  • the Open Project of Xinjiang Medical Engineering Innovation Research and Biomedical Transformation Key Laboratory
  • the 2026 Xinjiang Medical University Research and Innovation Team Project
  • the Tianshan Innovation Team Project in Xinjiang Uygur Autonomous Region
  • Distinguished Young Scholars Program at Xinjiang Medical University Affiliated Cancer Hospital

Zitieren

APA

Guo, F., Keremu, Y., Zhao, G., Hu, H., Wu, Y., Yu, X., Hao, C., Kong, W., & Ma, X. (2026). Integrating SERPINE1 Genotype With Clinical Indicators Improves Venous Thromboembolism Risk Prediction in Cancer Patients: A Retrospective Cohort Study From Xinjiang. Clinical and Applied Thrombosis/Hemostasis, 32. https://doi.org/10.1177/10760296261503703

Vancouver

Guo F, Keremu Y, Zhao G, Hu H, Wu Y, Yu X, et al. Integrating SERPINE1 Genotype With Clinical Indicators Improves Venous Thromboembolism Risk Prediction in Cancer Patients: A Retrospective Cohort Study From Xinjiang. Clinical and Applied Thrombosis/Hemostasis. 2026;32. doi:10.1177/10760296261503703

BibTeX
@article{Guo2026,
  author = {Guo, Fan and Keremu, Yiliminuer and Zhao, Gang and Hu, Huiting and Wu, Yufei and Yu, Xiaolu and Hao, Chongxiao and Kong, Weina and Ma, Xiumin},
  title = {Integrating SERPINE1 Genotype With Clinical Indicators Improves Venous Thromboembolism Risk Prediction in Cancer Patients: A Retrospective Cohort Study From Xinjiang},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2026},
  volume = {32},
  doi = {10.1177/10760296261503703}
}
Kostenlos starten →